一种新型的获得性通用性脂质疏松症的亚型,与皮下泛炎 - - 类似T细胞淋巴瘤相关
Fieke W Hoff1, Chao Xing2, Abhimanyu Garg1,3
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
JCEM case reports
|April 29, 2024
概括
获得的泛性脂质变 (AGL) 是一种罕见的脂肪损失疾病. 这一案例突显出一种潜在的新型AGL亚型,与T细胞淋巴瘤和泛肠炎有关.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 遗传学 遗传学 是一个
背景情况:
- 获得的泛性脂质缩 (AGL) 是一种罕见的疾病,其特征是皮下脂肪组织的广泛损失.
- 它的病因往往不清楚,尽管与自身免疫性疾病和胰腺炎的关联是公认的.
相关概念视频
Type I Diabetes I: Introduction
89
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
89
Type I Diabetes II: Pathophysiology
122
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
122


